| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.69B | 79.09B | 78.61B | 82.92B | 75.95B | 73.62B |
| Gross Profit | 15.01B | 14.19B | 14.18B | 14.85B | 15.66B | 16.00B |
| EBITDA | 4.12B | 3.81B | -1.21B | 2.13B | 5.42B | 7.29B |
| Net Income | 712.00M | 427.00M | -8.21B | -1.20B | 1.52B | 3.21B |
Balance Sheet | ||||||
| Total Assets | 78.25B | 79.50B | 82.66B | 86.22B | 80.12B | 76.86B |
| Cash, Cash Equivalents and Short-Term Investments | 6.98B | 7.72B | 6.85B | 6.89B | 7.59B | 8.13B |
| Total Debt | 14.65B | 14.65B | 14.65B | 11.10B | 5.20B | 5.20B |
| Total Liabilities | 39.52B | 40.17B | 43.11B | 40.01B | 32.39B | 30.47B |
| Stockholders Equity | 38.73B | 39.34B | 39.55B | 46.21B | 47.73B | 46.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.11B | -2.37B | -5.91B | -1.41B | -733.00M |
| Operating Cash Flow | 0.00 | 2.69B | 1.88B | -1.07B | 4.71B | 4.51B |
| Investing Cash Flow | 0.00 | -1.92B | -3.79B | -4.48B | -5.03B | -2.83B |
| Financing Cash Flow | 0.00 | -1.25B | 1.76B | 4.55B | -860.00M | -650.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥41.85B | 5.81 | ― | 3.53% | -3.45% | 30.52% | |
71 Outperform | ¥33.41B | 15.24 | ― | 3.45% | 4.17% | 23.25% | |
65 Neutral | ¥88.74B | 17.82 | ― | 0.67% | 10.18% | -14.36% | |
64 Neutral | ¥24.57B | 17.30 | ― | 4.09% | 3.31% | -70.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | ¥21.22B | 15.68 | ― | 1.39% | -0.12% | ― | |
50 Neutral | ¥8.77B | 23.47 | ― | 2.97% | 9.92% | -27.64% |